On Sunday, the Food and Drug Administration issued emergency-use authorization for 30 million doses of hydroxychloroquine sulfate and 1 million doses of chloroquine phosphate. The two drugs commonly used to treat malaria have shown potential as a COVID-19 treatment, according to the Department of Health and Human Services, but more clinical trials are needed to definitively assess their effectiveness.
(John Phillips // Getty Images)